0%
0%
0%
0%
0%
About ENTHEON BIOMEDICAL CORP
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Timothy Ko
Website
entheonbiomedical.com
Headquarters
Vancouver
Founded
2010
ISIN
CA29383X1033
Entheon Biomedical Corp. is a biotechnology company, which engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on June 17, 2019 and is headquartered in Vancouver, Canada.
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
